Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
about
sameAs
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiportersG-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasisLack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndromeG6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunctionControl of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagonThe SLC37 family of sugar-phosphate/phosphate exchangersNuclear receptors and epigenetic signaling: novel regulators of glycogen metabolism in skeletal muscleStrategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamilyHistidine 167 is the phosphate acceptor in glucose-6-phosphatase-beta forming a phosphohistidine enzyme intermediate during catalysisGlycogen storage disease type I and G6Pase-β deficiency: etiology and therapyA potential new role for muscle in blood glucose homeostasisBone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functionsGlycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis FunctionIdentification and characterisation of a new human glucose-6-phosphatase isoformMinireview: the SRC family of coactivators: an entrée to understanding a subset of polygenic diseases?Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapyAdeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia.Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane.Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver diseaseSilencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin.Oxidative stress mediates nephropathy in type Ia glycogen storage disease.Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type IaNeutropenia in type Ib glycogen storage diseaseStructure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type Ib.Recombinant AAV-directed gene therapy for type I glycogen storage diseases.Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation.Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer.Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type Ib.Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function.Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.The SLC37 family of phosphate-linked sugar phosphate antiporters.Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type IbAngiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type IaStem cell therapy for inherited metabolic disorders of the liver.Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease
P2860
Q21091009-10F7D500-A903-4481-A925-ECAC860F759DQ24606712-68CA661E-2941-4B89-AB6E-960F034AB1C8Q24613779-7C373039-E8BE-49F5-BA08-494490DE33C8Q24621013-51D1063B-B54D-4120-A115-2F5247DC8B79Q24624586-5E5F5E37-20FE-44D0-A076-5B496FD5885DQ26865636-B0A9584A-FED8-40F0-92F8-41E0B932EA2CQ27004919-D200BF3B-DDFE-45F4-833A-A85FB276514FQ27010565-93F362C3-338C-4B43-AA5F-E23A2E5F0FBCQ28119022-557F7FCF-E63B-4C99-B571-B13B1E7863C9Q28296663-526352E9-222F-407F-B3E4-EE90B11CBBE5Q28508734-E1E7EDED-5CE4-4692-A4EE-2E1248912806Q28513160-6E7CB475-3B25-454B-8936-6CDC73FF2C18Q28587708-A401D785-AD02-4546-8E20-A242CA8C47B8Q28592552-7ABE3928-33FB-4403-BAC0-A54EBB78F553Q28634725-7E6A5B01-3B73-4A18-87ED-4FED0C3EF8B3Q33634287-0D8AADF1-8D02-405A-8CDC-EEC5EBCE93D9Q33930092-195B2663-7782-4EC6-A257-E203D511EC66Q34123293-C082B44D-0E25-4F17-80C8-12D741030A54Q34197575-EB6AF690-F155-401A-83CF-4FEEBBB63647Q34308684-10872C37-8274-4197-807D-0025C9DEB505Q34321129-10389197-B4C0-4EAC-81DD-F405938362D7Q34521347-0BA3DC39-FE83-43BB-9AE3-37C1B8343077Q34652348-0D451B1C-2020-4F3E-8103-ED29386C432DQ34807521-97E2727D-D319-411C-9714-E7C0344F8FF9Q34891591-0D5C094A-C55A-4213-A9EA-EB695B76D388Q34996563-4716CF18-2882-4613-A970-2448F472E118Q34996612-CC633704-FC41-4D1D-9D3E-8E7C920AB8F5Q35078590-1D732399-85A8-4BC7-AC4B-5FE1365701ADQ35635511-772FB4D7-6249-43A7-99CF-5C31D2C8B11EQ35720799-50A1FB7C-DC42-4C15-AAB2-2377D131B815Q35953403-3F9CEA36-757C-4C67-9C26-07D10591AFC5Q35991536-0AAABB0F-E8E3-46F1-B99F-267FEC1E285FQ36174520-AE75C885-5FF4-4F86-9B6A-3A279BC1BB8EQ36340576-73F8BF6B-C725-47D7-9F67-978E37F387D7Q36571603-9F9EC2DD-8887-4D41-99D2-B802C6358C1DQ36700318-B721CAFD-6245-4B6A-9070-5723FC24B7E2Q36713557-06A5171A-1F76-4EEF-802D-0C11D0768292Q36717914-7B277E82-A24C-4755-8A83-E6C211E78BE6Q36744280-24C3016D-7E06-43E7-B802-5E36E78433C4Q36777763-AE1201FE-FCB2-4F60-B472-4F6CFB1AE237
P2860
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
description
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
scientific article (publication date: March 2002)
@en
vedecký článok (publikovaný 2002-03)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-03)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в березні 2002
@uk
مقالة علمية (نشرت في مارس 2002)
@ar
name
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@ast
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@en
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@nl
type
label
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@ast
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@en
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@nl
prefLabel
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@ast
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@en
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@nl
P2093
P3181
P356
P1476
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
@en
P2093
Dietrich Matern
Janice Yang Chou
Yuan-Tsong Chen
P304
P3181
P356
10.2174/1566524024605798
P407
P577
2002-03-01T00:00:00Z